Adsorption of doxorubicin on poly(methyl methacrylate)-chitosan-heparin- coated activated carbon beads

Langmuir

Volumn 28, Issue 9, 2012, Pages 4396-4403

  Miao, Jianjun ^a,c   Zhang, Fuming ^b,c   Takieddin, Majde ^d   Mousa, Shaker ^d   Linhardt, Robert J ^a,b,c  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b Research Rensselaer Polytechnic Institute   (United States)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^d ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON BEADS; ADSORPTION SYSTEM; BLOOD COMPATIBILITY; CANCER DRUG; CARBON BEADS; CHITOSAN COATINGS; COSOLVENTS; DOXORUBICIN; ETHYL ACETATES; FILTER CARTRIDGE; FREUNDLICH MODELS; HIGH DOSE; HYBRID COATING; MULTI-LAYER-COATING; PHOSPHATE-BUFFERED SALINES; PMMA COATINGS; POTENTIAL APPLICATIONS; THREE COMPONENT;

ACETONE; ACTIVATED CARBON; ADSORBENTS; ADSORPTION; BIOCOMPATIBILITY; CHEMOTHERAPY; CHITOSAN; COATINGS; DRUG DOSAGE; ESTERS; POLYSACCHARIDES; SCANNING ELECTRON MICROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY;

MULTILAYERS;

CHARCOAL; CHITOSAN; DOXORUBICIN; HEPARIN; POLY(METHYL METHACRYLATE);

ADSORPTION; ARTICLE; CHEMISTRY; X RAY PHOTOELECTRON SPECTROSCOPY;

ADSORPTION; CHARCOAL; CHITOSAN; DOXORUBICIN; HEPARIN; PHOTOELECTRON SPECTROSCOPY; POLYMETHYL METHACRYLATE;

EID: 84863270630     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la3000137     Document Type: Article

References (19)

1. Eckman, W. W.; Patlak, C. S.; Fenstermacher, J. D. Critical evaluation of principles governing advantages of intra-arterial infusions J. Pharmacokinet. Biopharm. 1974, 2 (3) 257-285
2. Vermorken, J. B. The role of chemotherapy in squamous-cell carcinoma of the uterine cervix-A review Int. J. Gynecol. Cancer 1993, 3 (3) 129-142
3. Kusunoki, N.; Ku, Y.; Tominaga, M.; Iwasaki, T.; Fukumoto, T.; Muramatsu, S.; Sugimoto, T.; Tsuchida, S.; Takamatsu, M.; Suzuki, Y.; Kuroda, Y. Effect of sodium thiosulfate on cisplatin removal with complete hepatic venous isolation and extracorporeal charcoal hemoperfusion: A pharmacokinetic evaluation Ann. Surg. Oncol. 2001, 8 (5) 449-457
4. Tominaga, M.; Ku, Y.; Iwasaki, T.; Suzuki, Y.; Kuroda, Y.; Saitoh, Y. Pharmacological evaluation of portal venous isolation and charcoal haemoperfusion for high-dose intra-arterial chemotherapy of the pancreas Br. J. Surg. 1997, 84 (8) 1072-1076
5. Jones, A.; Alexander, H. R. Development of isolated hepatic perfusion for patients who have unresectable hepatic malignancies Surg. Oncol. Clin. N. Am. 2008, 17 (4) 857-876
6. Maruo, T.; Motoyama, S.; Hamana, S.; Yoshida, S.; Ohara, N.; Yamasaki, M.; Ku, Y. Percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma Surg. Oncol. Clin. N. Am. 2008, 17 (4) 843-856
7. Carvalho, C.; Santos, R. X.; Cardoso, S.; Correia, S.; Oliveira, P. J.; Santos, M. S.; Moreira, P. I. Doxorubicin: The good, the bad and the ugly effect Curr. Med. Chem. 2009, 16 (25) 3267-3285
8. Samuel, M.; Chow, P. K. H.; Shih-Yen, E. C.; Machin, D.; Soo, K. C. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma Cochrane Database Syst. Rev. 2009, 1 CD001199
9. Park, T. J.; Govindaiah, P.; Hwang, T.; Kim, E.; Choi, S. W.; Kim, J. H. Biocompatible charcoal composites prepared by ionic liquids for drug detoxification Macromol. Res. 2011, 19 (7) 734-738
10. Park, T. J.; Lee, S. H.; Simmons, T. J.; Martin, J. G.; Mousa, S. A.; Snezhkova, E. A.; Sarnatskaya, V. V.; Nikolaev, V. G.; Linhardt, R. J. Heparin-cellulose-charcoal composites for drug detoxification prepared using room temperature ionic liquids Chem. Commun. 2008, 40, 5022-5024
11. Jager, M.; Wilke, A. Comprehensive biocompatibility testing of a new PMMA-HA bone cement versus conventional PMMA cement in vitro J. Biomater. Sci., Polym. Ed. 2003, 14 (11) 1283-1298
12. Lim, C. K.; Yaacob, N. S.; Ismail, Z.; Halim, A. S. In vitro biocompatibility of chitosan porous skin regenerating templates (PSRTs) using primary human skin keratinocytes Toxicol. in Vitro 2010, 24 (3) 721-727
13. Wissink, M. J. B.; Beernink, R.; Pieper, J. S.; Poot, A. A.; Engbers, G. H. M.; Beugeling, T.; van Aken, W. G.; Feijen, J. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation Biomaterials 2001, 22 (2) 151-163
14. Han, J. Y.; Zhang, F. M.; Xie, J.; Linhardt, R. J.; Hiebert, L. M. Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin Cardiovasc. Diabetol. 2009, 8, 46-58
15. Mizuno, Y.; Hara, T.; Tachibana, S.; Uragoh, K.; Akazawa, K.; Ueda, K. Doxorubicin-heparin complex-Reduction of cardiotoxicity of doxorubicin J. Cancer Res. Clin. Oncol. 1995, 121 (8) 469-473
16. Kummerle, A.; Krueger, T.; Dusmet, M.; Vallet, C.; Pan, Y.; Ris, H. B.; Decosterd, L. A. A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: Matrix effect and heparin interference strongly influence doxorubicin measurements J. Pharm. Biomed. Anal. 2003, 33 (3) 475-494
17. VandeVord, P. J.; Matthew, H. W. T.; DeSilva, S. P.; Mayton, L.; Wu, B.; Wooley, P. H. Evaluation of the biocompatibility of a chitosan scaffold in mice J. Biomed. Mater. Res. 2002, 59 (3) 585-590
18. Waugh, A.; Grant, A. Anatomy and Physiology in Health and Illness, 10 th ed.; Churchill Livingstone Elsevier: Edinburgh, U.K., 2007; p 22.
19. Chen, Z.; Pierre, D.; He, H.; Tan, S. H.; Chuong, P. H.; Hong, H.; Huang, J. L. Adsorption behavior of epirubicin hydrochloride on carboxylated carbon nanotubes Int. J. Pharm. 2011, 405 (1-2) 153-161